ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 420

Accelerated Knee Osteoarthritis Is Characterized By Destabilizing Meniscal Tears and Pre-Radiographic Structural Disease Burden

Jeffrey B. Driban1, Julie Davis2, Bing Lu3, Lori Lyn Price4,5, Robert J. Ward6, James MacKay7, Charles B. Eaton8, Grace H. Lo9, Mary Barbe10, Ming Zhang11, Jincheng Pang12, Alina Stout13, Matthew Harkey13 and Timothy E. McAlindon14, 1Medicine, Division of Rheumatology, Tufts Medical Center, Boston, MA, 2Rheumatology, Tufts Medical Center, BOSTON, MA, 3Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 4Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 5Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, 6Radiology, Tufts Medical Center, Boston, MA, 7Radiology, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 8Family Medicine and Community Health( Epidemiology), Alpert Medical School of Brown University, Pawtucket, RI, 9Michael E. DeBakey Veterans Affairs Medical Center / Baylor College of Medicine, Houston, TX, 10Temple University School of Medicine, Philadelphia, PA, 11Tufts Medical Center, Boston, MA, 12Electrical Engineering, Tufts University, Medford, MA, 13Rheumatology, Tufts Medical Center, Boston, MA, 14Division of Rheumatology, Tufts Medical Center, Boston, MA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: bone marrow lesions, Knee, Magnetic resonance imaging (MRI), meniscus and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Osteoarthritis – Clinical Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: A subset of adults who develop knee osteoarthritis (KOA) quickly progress from no radiographic disease to advanced-stage disease often in ≤12 months. Adults with accelerated KOA (AKOA) have greater pain and disability than those with common KOA even prior to radiographic onset. AKOA may be a unique endotype of KOA consequent on specific pathologies, as opposed to rapid evolution of common KOA; however, this hypothesis is untested. Hence, we aimed to determine if incident AKOA is preceded and characterized by distinct pathologic changes (e.g., subchondral bone damage), destabilizing meniscal tears (e.g., root/anchor tears) or other secondary feature changes; such as, diffuse meniscal pathology, greater quantitative changes in bone marrow lesions (BMLs) and articular cartilage than adults with common or no KOA.

Methods: We selected 3 sex-matched groups from the Osteoarthritis Initiative who had a knee without radiographic KOA at baseline (Kellgren-Lawrence [KL]<2): AKOA developed KL grade≥3 ≤48 months, common KOA increased radiographic scoring ≤48 months without meeting AKOA criteria, and no KOA had the same KL grades at baseline and 48 months. Observation period was up to 2 years before and after an index visit, which was when the AKOA or common KOA criteria were met (no KOA index visit was matched to AKOA). Radiologists reported meniscal and other distinct pathological findings. We quantified BML volume and cartilage damage on magnetic resonance (MR) images. We performed linear mixed models – adjusting for sex and factors related to missing MR data.

Results: Overall the groups were predominantly female (63%), overweight, and 33% reported frequent knee pain within a year of baseline. At 1 year before the index visit, >75% of adults with AKOA had multiple meniscal regions affected (diffuse pathology; vs common KOA: OR=3.19, 95% CI=1.70 to 5.97). By the index visit, adults with AKOA were twice as likely to have distinct pathology than those with common KOA (OR=2.19, 95% CI=1.01, 4.77; Figure 1). The most common distinct pathology affected the subchondral bone (i.e., subchondral fracture, acute attrition), which was found in 12.3% of adults with AKOA, 0.8% with common KOA, and 1.6% with no KOA.  Diffuse meniscal pathology was ubiquitous in AKOA; including 42% with a destabilizing meniscal tear (common KOA: 14%). These changes corresponded to larger BMLs and greater cartilage loss (Figure 1 and 2).

Conclusion: AKOA is characterized by destabilizing meniscal tears in a knee with greater pre-radiographic disease (e.g., diffuse meniscal pathology, large BMLs, greater cartilage loss)


A screenshot of text Description generated with very high confidence

A close up of a map Description generated with high confidence

 


Disclosure: J. B. Driban, None; J. Davis, None; B. Lu, None; L. L. Price, None; R. J. Ward, None; J. MacKay, None; C. B. Eaton, None; G. H. Lo, None; M. Barbe, None; M. Zhang, None; J. Pang, None; A. Stout, None; M. Harkey, None; T. E. McAlindon, None.

To cite this abstract in AMA style:

Driban JB, Davis J, Lu B, Price LL, Ward RJ, MacKay J, Eaton CB, Lo GH, Barbe M, Zhang M, Pang J, Stout A, Harkey M, McAlindon TE. Accelerated Knee Osteoarthritis Is Characterized By Destabilizing Meniscal Tears and Pre-Radiographic Structural Disease Burden [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/accelerated-knee-osteoarthritis-is-characterized-by-destabilizing-meniscal-tears-and-pre-radiographic-structural-disease-burden/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/accelerated-knee-osteoarthritis-is-characterized-by-destabilizing-meniscal-tears-and-pre-radiographic-structural-disease-burden/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology